TrialRespiratory research2022

Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.

Ilaria Galgani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.